@recursionpharma : Today we announced that our Phase 2 trial of REC-994 for the potential treatment of Cerebral Cavernous Malformations (#CCM) has reached full enrollment. Learn more: ir.recursion.com/news-releases/… • TwiCopy

Recursion

@recursionpharma

+ Follow

Decoding biology to radically improve lives. The industrial revolution of drug discovery is here.

ID: 2615770806

linkhttp://www.recursion.com calendar_today10-07-2014 16:41:56

3,3K Tweet

14,14K Followers

780 Following

Recursion

@recursionpharma

2 years ago

Today we announced that our Phase 2 trial of REC-994 for the potential treatment of Cerebral Cavernous Malformations (#CCM) has reached full enrollment. Learn more: ir.recursion.com/news-releases/…

thumb_up_off_alt39

chat_bubble_outline5

repeat11

shareShare